David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for ...

The early results of trials for two injectable, investigational antiretroviral therapies, VH4524184 and VH4011499, have the ...

Celltrion has launched Steqeyma (ustekinumab-stba), its biosimilar of Stelara (ustekinumab), at list price at an 85% discount ...

In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

The new bill would also require state Medicaid programs to report National Average Drug Acquisition Costs (NADAC) as a way to ...

When disasters occur, organizations such as SCAN Health Plan take a holistic approach, considering the needs of members, ...

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

Researchers said alpha particles are promising therapies that target cancer while minimizing the damage to nearby healthy tissues.

A Columbia University dermatologist argues that physicians in her specialty should be on the lookout for metabolic syndrome ...

Prevalence varies by region and is impacted by social stigma, access to preventive medicine and a lack of HIV/AIDS education, ...